BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:41:00 PM | Browse: 1053 | Download: 788
Publication Name World Journal of Gastroenterology
Manuscript ID 3472
Country Japan
Received
2013-05-01 14:37
Peer-Review Started
2013-05-03 16:27
To Make the First Decision
2013-06-09 10:12
Return for Revision
2013-06-18 11:06
Revised
2013-06-19 07:35
Second Decision
2013-08-08 19:22
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-08-09 01:08
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-08-21 23:05
Typeset the Manuscript
2013-08-28 17:08
Publish the Manuscript Online
2013-09-14 11:17
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Autobiography
Article Title Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers
Manuscript Source Invited Manuscript
All Author List Masaki Takayama, Shigenaga Matsui, Masanori Kawasaki, Yutaka Asakuma, Toshiharu Sakurai, Hiroshi Kashida and Masatoshi Kudo
Funding Agency and Grant Number
Corresponding Author Masaki Takayama, MD, Department of Gastroenterology and Hepatology, Kinki University, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka 589-8511, Japan. masaki0742@yahoo.co.jp
Key Words Early gastric cancer; Rebamipide; Endoscopic submucosal dissection; Gastric ulcer; Proton-pump inhibitor
Core Tip In this prospective randomized, parallel-controlled study, we demonstrated that rebamipide monotherapy was as effective as proton-pump inhibitor (PPI) in the healing of endoscopic submucosal dissection-induced ulcers, regardless of the location of the resected cancer, the degree of atrophic gastritis, or the presence of Helicobacter pylori infection. In addition, rebamipide treatment is more cost-effective and results in a better quality of ulcer healing compared with the PPI lansoprazole.
Publish Date 2013-09-14 11:17
Citation Takayama M, Matsui S, Kawasaki M, Asakuma Y, Sakurai T, Kashida H, Kudo M. Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers. World J Gastroenterol 2013; 19(34): 5706-5712
URL http://www.wjgnet.com/1007-9327/full/v19/i34/5706.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i34.5706
Full Article (PDF) WJG-19-5706.pdf
Manuscript File 3472-Review.docx
Answering Reviewers 3472-Answering reviewers.pdf
Copyright License Agreement 3472-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 3472-Language certificate.pdf
Peer-review Report 3472-Peer reviewer(s).pdf
Scientific Editor Work List 3472-Scientific editor work list.doc